Anabolic-androgenic steroids are used worldwide to help athletes gain muscle mass and strength. Their use and abuse is associated with numerous side effects, including acute myocardial infarction (MI). We report a case of MI in a young 31-year-old bodybuilder. Because of the serious cardiovascular complications of anabolic steroids, physicians should be aware of their abuse and consequences.
Buckley WE, Yesalis CE III, Friedl KE, Anderson WA, Streit AL, Wright JEEstimated prevalence of anabolic steroid use among male high school seniors . JAMA. 1988;260:3441-3445.
2.
Welder AA, Melchert RBCardiotoxic effects of Cocaine and anabolic-androgenic steroids in the athlete . J Pharmacol Toxicol Methods. 1993;29:61-68.
3.
DuRant RH , Rickert VI, Ashworth US, Newman C., Slavens G.Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med. 1993;328: 922-926.
4.
Niemine MS, Ramo MY, Viitasalo M., et al. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J. 1996 ;17:1576-1583.
5.
Thiblin I., Petersson A.Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol. 2005;19:27-44.
6.
Urhausen A., Albers T., Kindermann W.Are the cardiac effects of anabolic steroid abuse in strength athletes reversible ? Heart. 2004;90:496-501.
7.
Varriale P., Mirzai-tehrane M., Sedighi A.Acute myocardial infarction associated with anabolic steroids in a young HIV-infected patient. Pharmacotherapy. 1999;19: 881-884.
8.
Parssinen M. , Kujala U., Vartiainen E., Sarna S., Seppala T.Increased premature mortality of competitive power-lifters suspected to have used anabolic agents. Int J Sports Med. 2000;21:225-227.
9.
Nakao J., Change WC, Murota SI, Orimo H.Testosterone inhibits prostacyclin production by rat aortic smooth muscle cells in culture. Atherosclerosis. 1981;39:203-209.
10.
Greenberg S. , George WR, Kadowitz PJ, Wilson WRAndrogen-induced enhancement of vascular reactivity . Can J Physiol Pharmacol. 1974;52:14-22.
11.
Rockhold RWCardiovascular toxicity of anabolic steroids . Annu Rev Pharmacol Toxicol. 1993;33:497-520.
12.
Glazer G.Atherogenic effects of anabolic steroids on serum lipid levels. Arch Intern Med. 1991;151:1925-1933.
